(125 days)
Not Found
No
The document does not mention AI, ML, or related terms, and the description focuses on traditional computer-assisted surgery based on optical tracking and pre-existing software modules.
No.
This device is a surgical guidance system used by orthopedic surgeons for planning and intraoperative assistance, but it does not directly treat a disease or condition itself.
No
This device is described as a planning and intraoperative guidance system for computer-assisted surgery, specifically for hip resurfacing. Its primary function is to assist in precise positioning of surgical components, not to diagnose a medical condition.
No
The device description explicitly states that the system comprises software for intraoperative surgical planning and supports computer assisted surgery based on a wireless optical tracking localization device. This indicates the system includes hardware components (the wireless optical tracking localization device) in addition to the software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is clearly described as a "planning and intraoperative guidance system to enable open or percutaneous computer assisted surgery." This involves assisting surgeons during a surgical procedure, not performing tests on samples taken from the body to diagnose or monitor a medical condition.
- Device Description: The description focuses on software for surgical planning and a wireless optical tracking localization device used during surgery. It does not mention any components or processes related to analyzing biological samples.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Providing diagnostic information based on sample analysis
- Using reagents or other materials to interact with samples
The device is a surgical navigation system, which falls under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
Stryker® Navigation System - iNfinitus Hip Resurfacing Module
The Stryker® Navigation System - iNfinitus Hip Resurfacing Module is intended as a planning and intraoperative guidance system to enable open or percutaneous computer assisted surgery. The system is indicated for any medical condition in which the use of computer assisted surgery may be appropriate, and where a reference to a rigid anatomical structure such as but not limited to the pelvis, or femur, can be identified.
The system is indicated for partial hip resurfacing, to assist in precise positioning of hip femoral resurfacing component.
The system must be used within the operating room and should be operated only by trained personnel such as orthopedic surgeons and clinic staff.
The Stryker Navigation System -- Nfinitus Hip Resurfacing Module is intended as a planning and intraoperalive guidance system to enable open or percutaneous computer assisted surgery. The system is indicated for any medical and tion in which the use of computer assisted surgery may be appropriate, and where a reference to a rigid anatomical stuch as but not limited to the pelvis, or femur, can be identified.
The system is indicated for partial hip resurfacing, to assist in precise positioning of the femoral resurfacing component.
The system should be operated only by trained personnel such as orthopedic surgeons and clinic staff.
Product codes
HAW
Device Description
Stryker® Navigation System - iNfinitus Hip Resurfacing Module is part of the product series of the Stryker® Navigation System. The system comprises software for intraoperative surgical planning and supports computer assisted surgery based on a wireless optical tracking localization device for the use in navigated hip resurfacing surgery.
The Stryker® Navigation System - iNfinitus Hip Resurfacing Module is based on the previously cleared Stryker® Navigation System - Hip Module. The Hip Resurfacing module is tailored to the workflow of hip resurfacing procedures and consists of planning and preparing the acetabular side with depth to seat measurement for the cup and planning and preparation tasks for the femoral component.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
pelvis, femur, hip
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Operating room; trained personnel such as orthopedic surgeons and clinic staff.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
K072271
4100 E. Milham Avenue
Kalamazoo, MI 49001
t: 269 323 7700 f: 800 965 6505 www.stryker.com
stryker
Instruments
| 510(k) Summary | ||
|---|---|---|
| Device Sponsor: | Stryker Instruments | |
| 4100 E. Milham Avenue | ||
| Kalamazoo, MI 49001 | ||
| (p) 269-323-7700 | ||
| (f) 269-324-5412 | DEC 1 8 2007 | |
| Registration No.: | 1811755 | |
| Trade Name: | Stryker® Navigation System - iNfinitus Hip Resurfacing Module | |
| Common Name: | Navigation System | |
| Classification Name: | Stereotaxic Instruments | |
| Equivalent to: | K022365 Stryker Navigation - Hip Module | |
| K063028 VectorVision Hip SR | ||
| Device Description: | Stryker® Navigation System - iNfinitus Hip Resurfacing Module is part of the | |
| product series of the Stryker® Navigation System. The system comprises software for | ||
| intraoperative surgical planning and supports computer assisted surgery based on a | ||
| wireless optical tracking localization device for the use in navigated hip resurfacing | ||
| surgery. | ||
| The Stryker® Navigation System - iNfinitus Hip Resurfacing Module is based on the | ||
| previously cleared Stryker® Navigation System - Hip Module. The Hip Resurfacing | ||
| module is tailored to the workflow of hip resurfacing procedures and consists of | ||
| planning and preparing the acetabular side with depth to seat measurement for the cup | ||
| and planning and preparation tasks for the femoral component. | ||
| Intended Use: | Stryker® Navigation System - iNfinitus Hip Resurfacing Module | |
| The Stryker® Navigation System - iNfinitus Hip Resurfacing Module is | ||
| intended as a planning and intraoperative guidance system to enable open or | ||
| percutaneous computer assisted surgery. The system is indicated for any medical | ||
| condition in which the use of computer assisted surgery may be appropriate, and | ||
| where a reference to a rigid anatomical structure such as but not limited to the pelvis, | ||
| or femur, can be identified. | ||
| Indications for Use: | The system is indicated for partial hip resurfacing, to assist in precise positioning of | |
| hip femoral resurfacing component. | ||
| The system must be used within the operating room and should be operated only by | ||
| trained personnel such as orthopedic surgeons and clinic staff. | ||
| Contraindications | ||
| • An immobile hip due to an existing condition, such as rheumatoid arthritis, | ||
| previous fracture, or fusion. |
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 1 8 2007
Stryker Corporation % Ms. Becky Ditty Regulatory Affairs 4100 E. Milham Avenue Kalamazoo, Michigan 49001
Re: K072271
Trade/Device Name: Stryker Navigation System - iNfinitus Hip Resurfacing Module Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: December 12, 2007 Received: December 13, 2007
Dear Ms. Ditty:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Ms. Becky Ditty
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket, Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark N. Wilkerson
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(K) Number (if known):
Device Name: Stryker Navigation System - iNfinitus Hip Resurfacing Module
Intended Use
The Stryker Navigation System -- Nfinitus Hip Resurfacing Module is intended as a planning and intraoperalive guidance system to enable open or percutaneous computer assisted surgery. The system is indicated for any medical and tion in which the use of computer assisted surgery may be appropriate, and where a reference to a rigid anatomical stuch as but not limited to the pelvis, or femur, can be identified.
Indications for Use
The system is indicated for partial hip resurfacing, to assist in precise positioning of the femoral resurfacing component.
The system should be operated only by trained personnel such as orthopedic surgeons and clinic staff.
Contraindication
- · An immobile hip due to an existing condition, such as rheumatoid arthritis, previous fracture, or fusion.
- · Surgical situation where increasing surgical time may be detrimental to the patient.
Prescription Use X (Part 21 CFR 801 Subpart D) and/or
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
R.N.
Division of General, Restorative. and Neurological Devices
510(k) Number K072271